Natera, Inc. announced a record-breaking second quarter with a 40% year-over-year revenue increase, highlighting strong performance in women's health and transplant testing. The company saw mid- to high single-digit growth in non-invasive prenatal testing (NIPT) and low double-digit growth in carrier screening volumes, surpassing revenue expectations. The transplant business, particularly cell-free DNA testing, continues to expand, reflecting a positive market transition. This robust growth and operational leverage signal a promising outlook for Natera's future performance.
Natera, Inc. presented at the 2026 Global Healthcare Conference, with Pluang's Health sector data as of Sep 21, 2026 21:11 WIB providing market context. Of 95 priced Health-sector US stocks tradable on Pluang, 54 rose and 39 fell today. Notable movers include HIMS at USD 28.67 with a 1-day change of +2.43%, ACB at USD 3.96 with +2.33%, and AMPH at USD 24.16 with +2.29%.
Alkermes plc's drug ALKS7290 demonstrated significant improvement in ADHD symptoms in a Phase 1b trial, with patients showing a 14- to 19-point gain on a 54-point scale within two weeks. This outperforms typical placebo effects, which range from 6 to...
Morgan Stanley upgraded NNN REIT from Neutral to Overweight due to its stable income and strong financial health. The REIT boasts a 99.1% occupancy rate and 97.5% fixed-rate debt, ensuring steady rental income and protection against interest rate hik...
Arm's stock fluctuated significantly in 2026 due to shifts in customer demand and supply confidence for its silicon manufacturing. Despite steady demand figures, the stock fell earlier in the year due to supply concerns but rallied strongly in Septem...
Bob's Discount Furniture is showing robust growth despite tough market conditions, with a market cap of $2.07 billion. Management aims to expand to 500 showrooms by 2035, achieve 9% annual revenue growth, and reach EBITDA of $683.7 million through di...
Bitcoin surged past $86,000, gaining 6% in a day and pushing its market cap to $1.72 trillion, close to its 2026 opening price of $87,575. The rally was driven by a massive short squeeze liquidating over $454 million in short positions within 24 hour...
